{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:15:40Z","timestamp":1773173740247,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T00:00:00Z","timestamp":1257897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T00:00:00Z","timestamp":1257897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1365-2133.2009.09585.x","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T15:32:44Z","timestamp":1257953564000},"page":"860-865","source":"Crossref","is-referenced-by-count":39,"title":["Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea &amp; Westminster TEN protocol"],"prefix":"10.1093","volume":"162","author":[{"given":"A.","family":"De Sica-Chapman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.B.","family":"Bunker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,11,11]]},"reference":[{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1445-2197.2007.04184.x","article-title":"Toxic epidermal necrolysis\/Stevens-Johnson syndrome: current trends in management","volume":"77","author":"Dalli","year":"2007","journal-title":"ANZ J Surg"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB2|cit2","first-page":"340","article-title":"Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids","volume":"180","author":"Herndon","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2005.06721.x","article-title":"Toxic epidermal necrolysis: current evidence, practical management and future directions","volume":"153","author":"Chave","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1365-4632.2007.03277.x","article-title":"Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"46","author":"Fromowitz","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","article-title":"Toxic epidermal necrolysis clinical guidelines","volume":"29","author":"Endorf","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.burns.2006.04.031","article-title":"Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis","volume":"33","author":"Paquet","year":"2007","journal-title":"Burns"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2005.11.012","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding","volume":"6","author":"French","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.cdd.4401185","article-title":"Protein-based therapeutic approaches targeting death receptors","volume":"10","author":"French","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB32|cit9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.0906-6705.2006.00426.x","article-title":"Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis","volume":"15","author":"Paquet","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1423-0410.2008.001036.x","article-title":"Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin","volume":"94","author":"Reipert","year":"2008","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000236201","article-title":"The effects of FK-506 and cyclosporin A on the proliferation of PHA-stimulated T cells in response to IL-2, IL-4 or IL-6","volume":"98","author":"Liu","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02887757","article-title":"Inhibitory effect of cyclosporin A on T lymphocyte DNA synthesis","volume":"12","author":"Li","year":"1992","journal-title":"J Tongji Med Univ"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00403-005-0607-3","article-title":"Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis","volume":"297","author":"Paquet","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2005.06925.x","article-title":"Granulocyte\/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed","volume":"154","author":"Cianfarani","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1365-2133.2002.49735.x","article-title":"Recalcitrant ulcers in necrobiosis lipoidica diabeticorum healed by topical granulocyte-macrophage colony-stimulating factor","volume":"147","author":"Evans","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2133.2007.07979.x","article-title":"Impaired cutaneous wound healing in granulocyte\/macrophage colony-stimulating factor knockout mice","volume":"157","author":"Fang","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.4049\/jimmunol.175.11.7085","article-title":"Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance","volume":"175","author":"Rutella","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/scd.2005.14.310","article-title":"CD4+ CD25+ lymphocyte and dendritic cell mobilization with intermediate doses of recombinant human granulocyte colony-stimulating factor in healthy donors","volume":"14","author":"Vela-Ojeda","year":"2005","journal-title":"Stem Cells Dev"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2133.2008.08516.x","article-title":"In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption","volume":"158","author":"Mizukawa","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2006.06361.x","article-title":"Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors","volume":"135","author":"Goldman","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.2009.09585.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09585.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09585.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09585.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:47:33Z","timestamp":1676382453000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/4\/860\/6642597"}},"subtitle":["G-CSF in TEN"],"short-title":[],"issued":{"date-parts":[[2009,11,11]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09585.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,11]]}}}